Pasar al contenido principal

UN MODELO PRE-CLINICO IN VITRO DE NOCICEPTORES HUMANOS PARA INVESTIGAR EL DIMORFISMO SEXUAL EN MIGRAÑA CRONICA Y RASTREAR CANDIDATOS A FARMACOS

RTI2018-097189-B-C21

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos I+D+i Retos de Investigación
Año convocatoria 2018
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSIDAD MIGUEL HERNANDEZ DE ELCHE

Resultados relacionados

Resultados totales (Incluyendo duplicados): 6
Encontrada(s) 1 página(s)

RUA. Repositorio Institucional de la Universidad de Alicante
Publicación Otros (Other)

Peimine, an Anti-Inflammatory Compound from Chinese Herbal Extracts, Modulates Muscle-Type Nicotinic Receptors

  • Alberola-Die, Armando
  • Encinar, José A.
  • Cobo, Raúl
  • Fernández-Ballester, Gregorio
  • González-Ros, José M.
  • Ivorra, Isabel
  • Morales, Andrés
  • Alberola-Die, Armando|||/items/0fb6b26e-4cbf-4bf0-8f91-1d4465199721
  • Ivorra, Isabel|||/items/44c8359b-0c55-43a5-8d7d-90a617ac94c1
  • Morales, Andrés|||/items/f916c232-b463-46c0-96c1-6b3dc08d6bd3
  • Cobo, Raúl|||/items/81dcfade-d42d-4c9a-93dc-3d162e1d1d85
Fritillaria bulbs are used in Traditional Chinese Medicine to treat several illnesses. Peimine (Pm), an anti-inflammatory compound from Fritillaria, is known to inhibit some voltage-dependent ion channels and muscarinic receptors, but its interaction with ligand-gated ion channels remains unexplored. We have studied if Pm affects nicotinic acetylcholine receptors (nAChRs), since they play broad functional roles, both in the nervous system and non-neuronal tissues. Muscle-type nAChRs were incorporated to Xenopus oocytes and the action of Pm on the membrane currents elicited by ACh (IAChs) was assessed. Functional studies were combined with virtual docking and molecular dynamics assays. Co-application of ACh and Pm reversibly blocked IACh, with an IC50 in the low micromolar range. Pm inhibited nAChR by: (i) open-channel blockade, evidenced by the voltage-dependent inhibition of IAch, (ii) enhancement of nAChR desensitization, revealed by both an accelerated IACh decay and a decelerated IACh deactivation, and (iii) resting-nAChR blockade, deduced from the IACh inhibition elicited by Pm when applied before ACh superfusion. In good concordance, virtual docking and molecular dynamics assays demonstrated that Pm binds to different sites at the nAChR, mostly at the transmembrane domain. Thus, Pm from Fritillaria bulbs, considered therapeutic herbs, targets nAChRs with high affinity, which might account for its anti-inflammatory actions.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Investigational drugs in early phase clinical trials targeting thermotransient receptor potential (thermoTRP) channels

  • Fernández-Carvajal, Asia
  • González-Muñiz, Rosario
  • Fernández-Ballester, Gregorio
  • Ferrer-Montiel, Antonio
Introduction: Thermo transient receptor potential (thermoTRP) channels are some of the most intensely pursued therapeutic targets of the past decade. They are considered promising targets of numerous diseases including chronic pain and cancer. Modulators of these proteins, in particular TRPV1-4, TRPM8 and TRPA1, have reached clinical development, but none has been approved for clinical practice yet. Areas covered: The therapeutic potential of targeting thermoTRP channels is discussed. The discussion is centered on our experience and on available data found in SciFinder, PubMed, and ClinicalTrials.gov database from the past decade. This review focuses on the therapeutic progress concerning this family of channels, including strategies to improve their therapeutic index for overcoming adverse effects. Expert opinion: Although thermoTRPs are pivotal drug targets, translation to the clinic has faced two key problems, (i) unforeseen side effects in Phase I trials and, (ii) poor clinical efficacy in Phase II trials. Thus, there is a need for (i) an enhanced understanding of the physiological role of these channels in tissues and organs and (ii) the development of human-based pre-clinical models with higher clinical translation. Furthermore, progress in nanotechnology-based delivery strategies will positively impact thermoTRP human pharmacology., We thank the support of AEI (grants RTI2018-097189-B-C2-1and RTC-2017-6507-1), with FEDER funds from EU “Una manera de hacer Europa” and UMH (grant PAR-2019)
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

DD04107-Derived neuronal exocytosis inhibitor peptides: Evidences for synaptotagmin-1 as a putative target

  • Butrón, Daniel
  • Zamora-Carreras, H.
  • Devesa, Isabel
  • Treviño, Miguel A.
  • Abian, Olga
  • Velázquez-Campoy, Adrián
  • Bonache de Marcos, María Ángeles
  • Lagartera, Laura
  • Martín-Martínez, Mercedes
  • González-Rodríguez, Sara
  • Baamonde, Ana
  • Fernández-Carvajal, Asia
  • Ferrer-Montiel, Antonio
  • Jiménez, M. Angeles
  • González-Muñiz, Rosario
15 pags, 8 figs, 3 tabs. -- Supplementary data to this article can be found online at https://doi.org/10.1016/j.bioorg.2021.105231., The analgesic peptide DD04107 (Pal-EEMQRR-NH2) and its acetylated analogue inhibit α-calcitonin gene-related peptide (α-CGRP) exocytotic release from primary sensory neurons. Examining the crystal structure of the SNARE-Synaptotagmin-1(Syt1) complex, we hypothesized that these peptides could inhibit neuronal exocytosis by binding to Syt1, hampering at least partially its interaction with the SNARE complex. To address this hypothesis, we first interrogate the role of individual side-chains on the inhibition of α-CGRP release, finding that E1, M3, Q4 and R6 residues were crucial for activity. CD and NMR conformational analysis showed that linear peptides have tendency to adopt α-helical conformations, but the results with cyclic analogues indicated that this secondary structure is not needed for activity. Isothermal titration calorimetry (ITC) measurements demonstrate a direct interaction of some of these peptides with Syt1-C2B domain, but not with Syt7-C2B region, indicating selectivity. As expected for a compound able to inhibit α-CGRP release, cyclic peptide derivative Pal-E-cyclo[EMQK]R-NH2 showed potent in vivo analgesic activity, in a model of inflammatory pain. Molecular dynamics simulations provided a model consistent with KD values for the interaction of peptides with Syt1-C2B domain, and with their biological activity. Altogether, these results identify Syt1 as a potential new analgesic target., This work was supported by the Spanish Ministerio de Economía y Competitividad (MINECO-FEDER), RTI2018-097189-C2 and CTQ2017-84371-P), and the Spanish National Research Council (CSIC, 201880E109, 201980E030). The NMR experiments were performed in the “Manuel Rico” NMR laboratory, LMR, CSIC, a node of the Spanish Large-Scale National Facility ICTS R-LRB. We thank Prof. Josep Rizo and R. Voleti (Dept. Biophysics, Biochemistry and Pharmacology, UT Southwestern Medical Center, Dallas, USA) for providing the clones required for expressing Syt1 and Syt7 proteins. SG-R and AB belong to the Instituto de Investigación Sanitaria del Principado de Asturias (ISPA)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

β-Lactam TRPM8 Antagonists Derived from Phe-Phenylalaninol Conjugates: Structure–Activity Relationships and Antiallodynic Activity

  • Martín-Escura, Cristina
  • Bonache, M. Ángeles
  • Medina, Jessy A.
  • Medina-Peris, Alicia
  • Andrés-López, Jorge De
  • González-Rodríguez, Sara
  • Kerselaers, Sara
  • Fernández-Ballester, Gregorio
  • Voets,Thomas
  • Ferrer-Montiel, Antonio
  • Fernández-Carvajal, Asia
  • González-Muñiz, Rosario
The protein transient receptor potential melastatin type 8 (TRPM8), a non-selective, calcium (Ca2+)-permeable ion channel is implicated in several pathological conditions, including neuropathic pain states. In our previous research endeavors, we have identified β-lactam derivatives with high hydrophobic character that exhibit potent and selective TRPM8 antagonist activity. This work describes the synthesis of novel derivatives featuring C-terminal amides and diversely substituted N′-terminal monobenzyl groups in an attempt to increase the total polar surface area (TPSA) in this family of compounds. The primary goal was to assess the influence of these substituents on the inhibition of menthol-induced cellular Ca2+ entry, thereby establishing critical structure–activity relationships. While the substitution of the tert-butyl ester by isobutyl amide moieties improved the antagonist activity, none of the N′-monobencyl derivatives, regardless of the substituent on the phenyl ring, achieved the activity of the model dibenzyl compound. The antagonist potency of the most effective compounds was subsequently verified using Patch-Clamp electrophysiology experiments. Furthermore, we evaluated the selectivity of one of these compounds against other members of the transient receptor potential (TRP) ion channel family and some receptors connected to peripheral pain pathways. This compound demonstrated specificity for TRPM8 channels. To better comprehend the potential mode of interaction, we conducted docking experiments to uncover plausible binding sites on the functionally active tetrameric protein. While the four main populated poses are located by the pore zone, a similar location to that described for the N-(3-aminopropyl)-2-[(3-methylphenyl)methoxy]-N-(2-thienylmethyl)-benzamide (AMTB) antagonist cannot be discarded. Finally, in vivo experiments, involving a couple of selected compounds, revealed significant antinociceptive activity within a mice model of cold allodynia induced by oxaliplatin (OXA)., This research was funded by funded by MCIN/AEI/10.13039/501100011033 “FEDER, Una manera de hacer Europa: grant numbers RTI2018-097189-B-C21 (to A.F.-M. and A.F.-C.), RTI2018-097189-B-C22 (to R.G.-M.), PID2021-126423OB-C21 (to A.F.-M. and A.F.-C.) and PID2021-126423OB-C21 (to R.G.-M.); Generalitat Valenciana: PROMETEO/2021/031 (to A.F.-M.); and Comunidad de Madrid: IND2017/BMD7673 (to R.G.-M.), Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

L-Menthol-Loadable Electrospun Fibers of PMVEMA Anhydride for Topical Administration

  • Mira, Amalia
  • Rubio, M.
  • Alarcón, David
  • Rodríguez-Cañas, Enrique
  • Fernández-Carvajal, Asia
  • Falcó, Alberto
  • Mallavia, Ricardo
Poly(methyl vinyl ether-alt-maleic anhydride) (PMVEMA) of 119 and 139 molecular weights (P119 and P139, respectively) were electrospun to evaluate the resulting fibers as a topical delivery vehicle for (L-)menthol. Thus, electrospinning parameters were optimized for the production of uniform bead-free fibers from 12% w/w PMVEMA (±2.3% w/w menthol) solutions, and their morphology and size were characterized by field emission scanning electron microscopy (FESEM). The fibers of P119 (F119s) and P139 (F139s) showed average diameter sizes of approximately 534 and 664 nm, respectively, when unloaded, and 837 and 1369 nm when loaded with menthol. The morphology of all types of fibers was cylindrical except for F139s, which mostly displayed a double-ribbon-like shape. Gas chromatography-mass spectrometry (GC-MS) analysis determined that not only was the menthol encapsulation efficiency higher in F139s (92% versus 68% in F119s) but also that its stability over time was higher, given that in contrast with F119s, no significant losses in encapsulated menthol were detected in the F139s after 10 days post-production. Finally, in vitro biological assays showed no significant induction of cytotoxicity for any of the experimental fibers or in the full functionality of the encapsulated menthol, as it achieved equivalent free-menthol levels of activation of its specific receptor, the (human) transient receptor potential cation channel subfamily M (melastatin) member 8 (TRPM8)., This research was funded by the Spanish Ministry of Economy and Competitiveness and European ERDF Funds (MCIU/AEI/FEDER, EU) (RTI2018-097189-B-C21 to A.F.-C., RTI2018-101969-J-I00 to A.F., and MAT-2017-86805-R to R.M.). E.R.-C. is a recipient of a PTA contract from the Spanish Ministry of Science and Innovation (PTA2018-015394-I). The FESEM equipment used in this work was funded by Generalitat Valenciana (Spain) and co-financed with ERDF funds (OP ERDF of Comunitat Valenciana (Spain) GVA-IDIFEDER_2018/020 “Una forma de hacer Europa”)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Identification of novel inhibitors of plant GH3 IAA-amido synthetases through molecular docking studies

  • Luque, Adrián
  • Blanes-Mira, Clara
  • Caballero, Lara
  • Martínez-Melgarejo, Purificación A.
  • Nicolás-Albujer, Miriam
  • Pérez-Alfocea, Francisco
  • Fernández-Ballester, Gregorio
  • Pérez-Pérez, José Manuel
Auxins play a critical role in several plant developmental processes and their endogenous levels are regulated at multiple levels. The enzymes of the GRETCHEN HAGEN 3 (GH3) protein family catalyze the conjugation of amino acids to indoleacetic acid (IAA), the major endogenous auxin. The GH3 proteins are encoded by multiple redundant genes in plant genomes, making it difficult to perform functional genetic studies to understand their role in auxin homeostasis. To address these challenges, we used a chemical approach that exploits the reaction mechanism of GH3 proteins to identify small molecule inhibitors of their activity from a defined chemical library. The study evaluated receptor-ligand complexes based on their binding energy and classified them accordingly. Docking algorithms were used to correct any deviations, resulting in a list of the most important inhibitory compounds for selected GH3 enzymes based on a normalized sum of energy. The study presents atomic details of protein-ligand interactions and quantifies the effect of several of the identified small molecule inhibitors on auxin-mediated root growth processes in Arabidopsis thaliana. The direct effect of these compounds on endogenous auxin levels was measured using appropriate auxin sensors and endogenous hormone measurements. Our study has identified novel compounds of the flavonoid biosynthetic pathway that are effective inhibitors of GH3 enzyme-mediated IAA conjugation. These compounds play a versatile role in hormone-regulated plant development and have potential applications in both basic research and agriculture, This research is supported by the grants RTI2018-097189-B-C21 and PID2021-126840OB-I00 funded by MCIN/AEI/10.13039/501100011033, and by the “ERDF A way of making Europe”. MNA held a research contract of the Conselleria d'Educació, Cultura i Sport of the Generalitat Valenciana, grant number EDGJID/2021/025. LC held a “Programa INVESTIGO” contract (INVEST/2022/247) from the Generalitat Valenciana, Peer reviewed